Healthcare Contract Manufacturing Market Size and Share - Growth Analysis Report and Forecast Trends (2026-2035)

The healthcare contract manufacturing market was valued at USD 285.54 Billion in 2025. It is poised to grow at a CAGR of 9.40% during the forecast period of 2026-2035, and reach USD 701.20 Billion by 2035. The market growth is driven by the rising outsourcing by pharmaceutical companies, increasing demand for cost-efficient production, growing biologics pipeline, expansion of manufacturing capacity, and stringent regulatory requirements ensuring quality compliance.

Key Market Trends and Insights

• By type of manufacturing, finished goods held the largest market share, accounting for about 52% during the historical period, driven by high demand for end-use products.
• By end user, pharmaceutical companies dominated, capturing above 44% market share during the historical period, supported by extensive outsourcing and large-scale production requirements.
• By region, North America led with approximately 46% market share during the historical period, driven by advanced manufacturing infrastructure and strong industry presence.

Market Size and Forecast

• Market Size (2025): USD 285.54 Billion
• Projected Market Size (2035): USD 701.20 Billion
• CAGR (2026-2035): 9.40%

Healthcare Contract Manufacturing Market Overview

The market is expanding consistently, driven by pharmaceutical companies' need to reduce costs, accelerate production timelines, and access specialized manufacturing expertise. From complex medical device assemblies to GMP facility-based pharmaceutical production, contract manufacturers address a broad therapeutic spectrum. Rising healthcare expenditure in emerging markets, Industry 4.0 automation adoption, and increasing regulatory complexity are compelling organizations toward strategic outsourcing, reinforcing sustained global market growth through the forecast period. The market reached a value of approximately USD 285.54 Billion in 2025.

Healthcare Contract Manufacturing Market Growth Drivers

Expansion of Sterile Manufacturing Capabilities Driving the Market Development

Escalating outsourcing demand and increasing preference for integrated drug-device solutions are acting as significant market drivers. For instance, in March 2026, Thermo Fisher expanded its U.S. sterile manufacturing footprint through collaboration with SHL Medical for autoinjector solutions. This development is expected to enhance sterile filling capabilities, improve end-to-end production efficiency, and accelerate contract manufacturing adoption throughout the forecast period.

Healthcare Contract Manufacturing Market Trends

Key trends shaping the market include rising outsourcing demand, expansion of biologics manufacturing capacity, increasing adoption of advanced technologies, strategic collaborations, and growing emphasis on regulatory compliance and quality standards.

Biologics Capacity Expansion Strengthening the Market Demand

The rising demand for biologics and expanding global manufacturing capacity are serving as major trends in the market. For instance, in January 2026, Samsung Biologics acquired a biologics manufacturing facility in Rockville, strengthening its U.S. presence. This initiative is anticipated to advance biologics manufacturing capabilities, support large-scale production, and reinforce competitive positioning amid growing outsourcing demand in the forecast period.

Healthcare Contract Manufacturing Market Segmentation

Market Breakup by Service

• Medical Device
• Service Accessories Manufacturing Assembly Manufacturing Component Manufacturing Device Manufacturing
• Therapeutic Area Cardiology Diagnostic Imaging Orthopaedic IVD Ophthalmic General and Plastic Surgery Drug Delivery Dental Endoscopy Diabetes Care Others
• Pharmaceutical
• Service API/Bulk Drugs Advanced Drug Delivery Formulation Packaging Finished Dose Formulations Solid Liquid Semisolid

Market Breakup by Type

• Sterile
• Non-Sterile

Market Breakup by Class

• Class I
• Class II
• Class III

Market Breakup by Type of Manufacturing

• Raw Material
• Electronics
• Finished Goods

Market Breakup by End User

• Medical Device Companies
• Pharmaceutical Companies
• Biopharmaceutical Companies

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Healthcare Contract Manufacturing Market Share

Pharmaceutical Companies Expected to Dominate the Market Segment by End User

Pharmaceutical companies dominated the market, capturing over 44% share in the historical period, supported by extensive outsourcing and large-scale production requirements. Their reliance on pharma CMO partnerships enables cost efficiency, scalability, and access to specialized expertise, strengthening supply chain capabilities and ensuring consistent production quality across global pharmaceutical operations and therapeutic segments.

Healthcare Contract Manufacturing Market Analysis by Region

North America led the market with approximately 46% share in the historical period, driven by advanced manufacturing infrastructure and strong industry presence. The region benefits from well-established GMP facility standards, ensuring high-quality production, regulatory compliance, and reliability, which continue to attract pharmaceutical companies seeking efficient and secure manufacturing partnerships globally.

Leading Players in the Healthcare Contract Manufacturing Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Thermo Fisher Scientific

Thermo Fisher Scientific, founded in 2006 and headquartered in Waltham, Massachusetts, USA, is a leading contract development and manufacturing organization. Its portfolio includes biologics production, clinical trial services, and sterile filling solutions supporting complex drug delivery systems. The company enables end-to-end pharmaceutical outsourcing across global markets. In March 2026, Thermo Fisher expanding its U.S. sterile manufacturing footprint through a collaboration with SHL Medical.

Lonza

Lonza, established in 1897 and headquartered in Basel, Switzerland, is a global CDMO specializing in biologics development and manufacturing. Its portfolio includes cell and gene therapy, mammalian production, and biologics manufacturing platforms supporting large-scale commercial supply. Lonza plays a critical role in enabling innovative therapies through advanced manufacturing expertise.

Celestica Inc.

Celestica Inc., founded in 1994 and headquartered in Toronto, Canada, provides advanced manufacturing and supply chain solutions. Its healthcare portfolio includes medical device production, precision electronics, and outsourcing strategy support for complex systems. The company enables scalable manufacturing capabilities for global healthcare and life sciences customers.

Integer Holdings Corporation

Integer Holdings Corporation, established in 1970 and headquartered in Plano, Texas, USA, is a leading medical device outsourcing manufacturer. Its portfolio includes implantable devices, components, and quality agreement-driven manufacturing solutions ensuring compliance and reliability. The company supports medical device firms with end-to-end production and engineering services.

Other key players in the market are Nordson Corporation, Sanmina Corporation, Phillips-Medisize - a Molex Company, Catalent, Inc, Boehringer Ingelheim International GmbH, Samsung Biologics, WuXi AppTec, Cambrex Corporation, and Recifarm.

Key Questions Answered in the Healthcare Contract Manufacturing Market Report

• What was the healthcare contract manufacturing market value in 2025?
• What is the healthcare contract manufacturing market forecast outlook for 2026-2035?
• What major factors aid the demand for healthcare contract manufacturing market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market’s major drivers, opportunities, and restraints?
• What are the major healthcare contract manufacturing market trends?
• Which service is expected to dominate the market segment?
• Which type is expected to dominate the market segment?
• Which class is expected to dominate the market segment?
• Which type of manufacturing is expected to dominate the market segment?
• Which end user is expected to dominate the market segment?
• Who are the key players in the healthcare contract manufacturing market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?